Novel Delivery System for High Dose Rate Intensity Modulated Brachytherapy with Yb-169 as a Radiation Source

以 Yb-169 作为放射源的高剂量率强度调制近距离放射治疗的新型输送系统

基本信息

  • 批准号:
    523394-2018
  • 负责人:
  • 金额:
    $ 10.44万
  • 依托单位:
  • 依托单位国家:
    加拿大
  • 项目类别:
    Collaborative Health Research Projects
  • 财政年份:
    2018
  • 资助国家:
    加拿大
  • 起止时间:
    2018-01-01 至 2019-12-31
  • 项目状态:
    已结题

项目摘要

Radiotherapy is an effective and safe treatment for cancer. Approximately 50% of cancer**patients benefit from this treatment, that is, close to 100,000 Canadians with cancer each**year. Brachytherapy, is a form of radiotherapy where radioactive sources are placed inside or**near the tumours using thin, hollow tubes (catheters) implanted for a short period of time,**giving a high radiation dose to the tumour while maintaining a low dose to surrounding healthy tissues. However, dose distribution in conventional brachytherapy is identical in all directions resulting in dose spillage to radiation sensitive**healthy tissues. This proposal aims to develop a novel radiation delivery system that will**manipulate the radiation dose to conform to the shape of a tumour by incorporating radiation**shields inside the implanted hollow tubes, i.e. the delivery system will modulate the intensity**of the emitted radiation from the brachytherapy source. The shields can rotate during the**treatment, direct the radiation towards the tumour and away from healthy tissues. Developing and making intensity**modulated brachytherapy clinically available, will significantly improve the potential of**brachytherapy with reduced toxicity will increase the cure rates and improve the quality of life**for Canadians with prostate, breast, cervical, uterine, vaginal, vulvar, head & neck and**oesophageal cancers. In addition, this proposal will offer undergraduate and graduate student**to work in a multidisciplinary environment with radiation oncology, radiation physics, biology,**computing and engineering.
放射治疗是一种有效和安全的癌症治疗方法。大约50%的癌症 ** 患者受益于这种治疗,即每年有近100,000名加拿大癌症患者 **。近距离放射治疗是一种放射疗法,其中放射源被放置在肿瘤内部或 ** 附近,使用短时间内植入的细空心管(导管),** 对肿瘤给予高辐射剂量,同时对周围健康组织保持低剂量。然而,传统近距离放射治疗中的剂量分布在所有方向上都是相同的,导致剂量溢出到辐射敏感的健康组织。该建议旨在开发一种新型辐射输送系统,该系统将通过在植入的中空管内结合辐射屏蔽来 ** 操纵辐射剂量以符合肿瘤的形状,即输送系统将调制从近距离放射治疗源发射的辐射的强度 **。防护罩可以在治疗过程中旋转,将辐射导向肿瘤,远离健康组织。发展和使强度 ** 调制近距离放射治疗在临床上可用,将显着提高 ** 近距离放射治疗的潜力,降低毒性,将提高治愈率,改善加拿大人前列腺癌,乳腺癌,宫颈癌,子宫癌,阴道癌,外阴癌,头颈癌和 ** 食管癌的生活质量。此外,该提案将为本科生和研究生提供在放射肿瘤学、放射物理学、生物学、计算和工程学等多学科环境中工作的机会。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

AbbasinejadEnger, Shirin其他文献

AbbasinejadEnger, Shirin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('AbbasinejadEnger, Shirin', 18)}}的其他基金

Novel Delivery System for High Dose Rate Intensity Modulated Brachytherapy with Yb-169 as a Radiation Source
以 Yb-169 作为放射源的高剂量率强度调制近距离放射治疗的新型输送系统
  • 批准号:
    523394-2018
  • 财政年份:
    2019
  • 资助金额:
    $ 10.44万
  • 项目类别:
    Collaborative Health Research Projects

相似国自然基金

应用RNA-only delivery基因回路靶向治疗CMS2型结肠癌的研究
  • 批准号:
    82003254
  • 批准年份:
    2020
  • 资助金额:
    16.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Development of a novel depot delivery system for a glaucoma therapeutic
开发用于青光眼治疗的新型储库递送系统
  • 批准号:
    10699791
  • 财政年份:
    2023
  • 资助金额:
    $ 10.44万
  • 项目类别:
SBIR Phase I: Development of a Novel, Sprayable, Large Volume Hydrogel Delivery System Platform
SBIR 第一阶段:开发新型、可喷雾、大容量水凝胶输送系统平台
  • 批准号:
    2304462
  • 财政年份:
    2023
  • 资助金额:
    $ 10.44万
  • 项目类别:
    Standard Grant
Development of a novel hydrogen sulfide delivery system responsive to the tumor microenvironment and its application to the treatment of refractory cancer
响应肿瘤微环境的新型硫化氢递送系统的开发及其在难治性癌症治疗中的应用
  • 批准号:
    23KJ1888
  • 财政年份:
    2023
  • 资助金额:
    $ 10.44万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
DEVELOPMENT OF UM-1098: A NOVEL SYNTHETIC TH17 INDUCING ADJUVANT AND DELIVERY SYSTEM
UM-1098 的开发:一种新型合成 TH17 诱导佐剂和递送系统
  • 批准号:
    10935819
  • 财政年份:
    2023
  • 资助金额:
    $ 10.44万
  • 项目类别:
Targeted Gene Delivery and Human Dendritic Cell Maturation Through a Novel Hybrid Biological-Biomaterial Vector System
通过新型混合生物-生物材料载体系统进行靶向基因递送和人类树突状细胞成熟
  • 批准号:
    10586414
  • 财政年份:
    2023
  • 资助金额:
    $ 10.44万
  • 项目类别:
A novel supersulfide delivery system for the treatment of psoriasis
一种用于治疗牛皮癣的新型超硫化物递送系统
  • 批准号:
    23K17215
  • 财政年份:
    2023
  • 资助金额:
    $ 10.44万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A novel drug delivery system for the prevention and rescue of fentanyl and other opioid overdoses
用于预防和救援芬太尼和其他阿片类药物过量的新型药物输送系统
  • 批准号:
    10636330
  • 财政年份:
    2023
  • 资助金额:
    $ 10.44万
  • 项目类别:
STTR Phase II: Developing a novel drug delivery system to enable an oral peptide-based drug for kidney stones
STTR II 期:开发一种新型药物输送系统,使基于口服肽的药物能够治疗肾结石
  • 批准号:
    2200058
  • 财政年份:
    2022
  • 资助金额:
    $ 10.44万
  • 项目类别:
    Cooperative Agreement
A novel compression and delivery system for hydrogen fuelling stations
一种用于加氢站的新型压缩和输送系统
  • 批准号:
    577669-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 10.44万
  • 项目类别:
    Alliance Grants
Novel ocular hypotensive and neuroprotective microparticle-based hydrogen sulfide delivery system
新型降眼压和神经保护微粒硫化氢输送系统
  • 批准号:
    10359973
  • 财政年份:
    2022
  • 资助金额:
    $ 10.44万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了